4.7 Review

Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target

Journal

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Volume 1762, Issue 11-12, Pages 1051-1067

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbadis.2006.03.008

Keywords

amyotrophic lateral sclerosis; oxidative stress; superoxide dismutase; anti-oxidant; clinical trials; therapy

Ask authors/readers for more resources

The cause(s) of amyotrophic lateral sclerosis (ALS) is not fully understood in the vast majority of cases and the mechanisms involved in motor neuron degeneration are multi-factorial and complex. There is substantial evidence to support the hypothesis that oxidative stress is one mechanism by which motor neuron death occurs. This theory becomes more persuasive with the discovery that mutation of the anti-oxidant enzyme, superoxide dismutase I (SOD I), causes disease in a significant minority of cases. However, the precise mechanism(s) by which mutant SOD I leads to motor neuron degeneration have not been defined with certainly, and trials of anti-oxidant therapies have been disappointing. Here, we review the evidence implicating oxidative stress in ALS pathogenesis, discuss how oxidative stress may affect and be affected by other proposed mechanisms of neurodegeneration, and review the trials of various anti-oxidants as potential therapies for ALS. (c) 2006 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available